Aspergillosis: Pathogenesis, clinical manifestations, and therapy

[1]  M. Boeckh,et al.  Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. , 2002, Blood.

[2]  Richard Sylvester,et al.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.

[3]  A. Voss,et al.  Contamination of hospital water with Aspergillus fumigatus and other molds. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Lawrence Corey,et al.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  E. Anaissie,et al.  Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. , 2002, The New England journal of medicine.

[6]  W. Thomson,et al.  Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. , 2001, The Journal of infectious diseases.

[7]  A. Alrajhi,et al.  Chronic invasive aspergillosis of the paranasal sinuses in immunocompetent hosts from Saudi Arabia. , 2001, The American journal of tropical medicine and hygiene.

[8]  C. Barnes,et al.  Aspergillus laryngotracheobronchial infection in a 6-year-old girl following bone marrow transplantation. , 2001, International journal of pediatric otorhinolaryngology.

[9]  J. Baddley,et al.  Invasive mold infections in allogeneic bone marrow transplant recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  J. Verhaegen,et al.  Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. , 2001, Blood.

[11]  B. Nussenbaum,et al.  Characteristics of Bony Erosion in Allergic Fungal Rhinosinusitis , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[12]  S J Lin,et al.  Aspergillosis case-fatality rate: systematic review of the literature. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  S. Gaur,et al.  Prevalence of allergic bronchopulmonary aspergillosis in patients with bronchial asthma. , 2000, Asian Pacific journal of allergy and immunology.

[14]  B. Bewig,et al.  Topical amphotericin B application in severe bronchial aspergillosis after lung transplantation: report of experiences in 3 cases. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  D. Denning,et al.  Antifungal drug resistance in Aspergillus. , 2000, The Journal of infection.

[16]  E. Spitznagel,et al.  Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. , 2000, The Journal of allergy and clinical immunology.

[17]  F. Lampe,et al.  Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  J. Perfect,et al.  Anastomotic infections in lung transplant recipients. , 2000, Annals of transplantation.

[19]  D. Niederwieser,et al.  Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants. , 2000, The Journal of hospital infection.

[20]  V. Kurup,et al.  T Cell Vaccination in Mice with Invasive Pulmonary Aspergillosis1 , 2000, The Journal of Immunology.

[21]  J. Harousseau,et al.  Itraconazole Oral Solution for Primary Prophylaxis of Fungal Infections in Patients with Hematological Malignancy and Profound Neutropenia: a Randomized, Double-Blind, Double-Placebo, Multicenter Trial Comparing Itraconazole and Amphotericin B , 2000, Antimicrobial Agents and Chemotherapy.

[22]  D. Kontoyiannis,et al.  Significance of aspergillemia in patients with cancer: a 10-year study. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  H. Dhong,et al.  Diagnostic Accuracy in Sinus Fungus Balls: CT Scan and Operative Findings , 2000, American journal of rhinology.

[24]  L. Koh,et al.  Pseudomembranous tracheobronchitis caused by Aspergillus in a patient after peripheral blood stem cell transplantation. , 2000, Annals of the Academy of Medicine, Singapore.

[25]  William R. Kirkpatrick,et al.  Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes , 2000, Medicine.

[26]  A. Wells,et al.  Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm. , 2000, Chest.

[27]  R. Bush,et al.  Report of successful prolonged antifungal therapy for refractory allergic fungal sinusitis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  F. Lippek,et al.  Fulminant tracheobronchial and pulmonary aspergillosis complicating imported Plasmodium falciparum malaria in an apparently immunocompetent woman. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  K. Langfelder,et al.  Interaction of Human Phagocytes with PigmentlessAspergillus Conidia , 2000, Infection and Immunity.

[30]  F. Kuhn,et al.  Allergic Fungal Sinusitis: A Four-Year Follow-Up , 2000, American journal of rhinology.

[31]  S. Stringer,et al.  Chronic invasive fungal rhinosinusitis. , 2000, Otolaryngologic clinics of North America.

[32]  V. Kurup,et al.  Fungal allergens and peptide epitopes☆ , 2000, Peptides.

[33]  D. Denning,et al.  Practice Guidelines for Diseases Caused by Aspergillus , 2000 .

[34]  B. Ferguson.  Fungus balls of the paranasal sinuses. , 2000, Otolaryngologic clinics of North America.

[35]  A. Degraff,et al.  A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. , 2000, The New England journal of medicine.

[36]  S. Kohno,et al.  Clinical evaluation of 61 patients with pulmonary aspergilloma. , 2000, Internal medicine.

[37]  G. Verhoef,et al.  Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis , 1999, Journal of Clinical Microbiology.

[38]  D. Voelker,et al.  Binding of Rat and Human Surfactant Proteins A and D to Aspergillus fumigatus Conidia , 1999, Infection and Immunity.

[39]  B. Sterman.  Sinus Surgery in Bone Marrow Transplantation Patients , 1999, American journal of rhinology.

[40]  S. Sanche,et al.  In Vitro Amphotericin B Resistance in Clinical Isolates of Aspergillus terreus, with a Head-to-Head Comparison to Voriconazole , 1999, Journal of Clinical Microbiology.

[41]  K. S. Lee,et al.  Halo sign on high resolution CT: findings in spectrum of pulmonary diseases with pathologic correlation. , 1999, Journal of computer assisted tomography.

[42]  A. Prentice,et al.  A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies , 1999 .

[43]  J. Latgé,et al.  Aspergillus fumigatus and Aspergillosis , 1999, Clinical Microbiology Reviews.

[44]  R. Finberg,et al.  Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia , 1999 .

[45]  J. Latgé,et al.  Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  A. Favero,et al.  Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  D. Denning,et al.  Aspergillus fumigatus catalases: cloning of an Aspergillus nidulans catalase B homologue and evidence for at least three catalases. , 1999, FEMS immunology and medical microbiology.

[48]  Sumio Kawamura,et al.  Comparison between PCR and Detection of Antigen in Sera for Diagnosis of Pulmonary Aspergillosis , 1999, Journal of Clinical Microbiology.

[49]  A. Mencacci,et al.  Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. , 1998, The Journal of infectious diseases.

[50]  M. Bergeron,et al.  Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. , 1998, The Journal of infectious diseases.

[51]  S. Holland,et al.  Aspergillus nidulans Infection in Chronic Granulomatous Disease , 1998, Medicine.

[52]  B. Marple,et al.  Comprehensive Management of Allergic Fungal Sinusitis , 1998, American journal of rhinology.

[53]  K. Kwon-Chung,et al.  The Developmentally Regulated alb1 Gene ofAspergillus fumigatus: Its Role in Modulation of Conidial Morphology and Virulence , 1998, Journal of bacteriology.

[54]  D. De Bacquer,et al.  Impact of previous aspergillosis on the outcome of bone marrow transplantation. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  J. Latgé,et al.  Cloning and disruption of the antigenic catalase gene of Aspergillus fumigatus , 1997, Infection and immunity.

[56]  D. Kirschmann,et al.  The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. , 1997, Journal of immunology.

[57]  D. Stevens,et al.  Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria. , 1997, Archives of internal medicine.

[58]  Yih-Leong Chang,et al.  Surgical treatment for pulmonary aspergilloma: a 28 year experience , 1998 .

[59]  H. Einsele,et al.  Detection and identification of fungal pathogens in blood by using molecular probes , 1997, Journal of clinical microbiology.

[60]  W. Leisenring,et al.  Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. , 1997, The Journal of infectious diseases.

[61]  E. Jantunen,et al.  Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients , 1997, Bone Marrow Transplantation.

[62]  J. Latgé,et al.  Th1 and Th2 cytokines in mice with invasive aspergillosis , 1997, Infection and immunity.

[63]  S. Hunt,et al.  Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. , 1997, Transplantation proceedings.

[64]  R. Filmon,et al.  Expression and identification of a laminin-binding protein in Aspergillus fumigatus conidia , 1997, Infection and immunity.

[65]  V. Kurup,et al.  Aspergillus fumigatus peptides differentially express Th1 and Th2 cytokines , 1996, Peptides.

[66]  A. Groll,et al.  Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. , 1996, The Journal of infection.

[67]  R. Slavin,et al.  T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. , 1996, The Journal of clinical investigation.

[68]  G. Robson,et al.  Evidence of multiple extracellular phospholipase activities of Aspergillus fumigatus , 1996, Infection and immunity.

[69]  J. Horvath,et al.  The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. , 1996, The American journal of medicine.

[70]  T. Walsh,et al.  Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression. , 1995, American journal of respiratory and critical care medicine.

[71]  N. Müller,et al.  Invasive pulmonary aspergillosis in AIDS: radiographic, CT, and pathologic findings. , 1995, Radiology.

[72]  J. Bouchara,et al.  Cell surface properties of Aspergillus fumigatus conidia: correlation between adherence, agglutination, and rearrangements of the cell wall. , 1995, Canadian journal of microbiology.

[73]  J. Corey,et al.  Allergic Fungal Sinusitis: Allergic, Infectious, or Both? , 1995, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[74]  R. Hay,et al.  Purification, N-terminal amino acid sequence and partial characterization of a Cu,Zn superoxide dismutase from the pathogenic fungus Aspergillus fumigatus. , 1995, Free radical research.

[75]  M. Vidaud,et al.  Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR , 1995, Journal of clinical microbiology.

[76]  R. Duthie,et al.  Aspergillus fungemia: report of two cases and review. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[77]  P. Heymann,et al.  Development of immune responses to Aspergillus at an early age in children with cystic fibrosis. , 1994, American journal of respiratory and critical care medicine.

[78]  J. Latgé,et al.  rodletless mutants of Aspergillus fumigatus , 1994, Infection and immunity.

[79]  S. Khoo,et al.  Invasive aspergillosis in patients with AIDS. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[80]  A. Levine,et al.  Asp f I CD4+ TH2-like T-cell lines in allergic bronchopulmonary aspergillosis. , 1994, The Journal of allergy and clinical immunology.

[81]  J. Perfect,et al.  NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. , 1994, The American journal of medicine.

[82]  J. Latgé,et al.  Isolation and characterization of a secreted metalloprotease of Aspergillus fumigatus , 1993, Infection and immunity.

[83]  C. Kemper,et al.  Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[84]  E. Michaliszyn,et al.  Acquired immunity in experimental murine aspergillosis is mediated by macrophages , 1993, Infection and immunity.

[85]  O. Lortholary,et al.  Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS. , 1993, The American journal of medicine.

[86]  C. Tang,et al.  The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis , 1993, Infection and immunity.

[87]  J. Armitage,et al.  Nosocomial Invasive Aspergillosis in Lymphoma Patients Treated with Bone Marrow or Peripheral Stem Cell Transplants , 1993, Infection Control & Hospital Epidemiology.

[88]  W. Gefter.  The spectrum of pulmonary aspergillosis. , 1992, Journal of thoracic imaging.

[89]  J. Latgé,et al.  Participation of complement in the phagocytosis of the conidia of Aspergillus fumigatus by human polymorphonuclear cells. , 1992, The Journal of infectious diseases.

[90]  H. Magnussen,et al.  [Invasive aspergillosis in cavitary lung sarcoidosis]. , 1992, Pneumologie.

[91]  M. Kramer,et al.  Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. , 1991, The American review of respiratory disease.

[92]  L. Rahalison,et al.  Isolation and characterisation of an extracellular alkaline protease of Aspergillus fumigatus. , 1991, Journal of medical microbiology.

[93]  A. Harris,et al.  Pseudomembranous tracheobronchitis caused by Aspergillus. , 1991, The American review of respiratory disease.

[94]  K. Kavanagh,et al.  Fungal Sinusitis in Immunocompromised Children with Neoplasms , 1991, The Annals of otology, rhinology, and laryngology.

[95]  D. Denning,et al.  Pulmonary aspergillosis in the acquired immunodeficiency syndrome. , 1991, The New England journal of medicine.

[96]  G. Talbot,et al.  Invasive aspergillus rhinosinusitis in patients with acute leukemia. , 1991, Reviews of infectious diseases.

[97]  W. Stanford,et al.  Fungal pulmonary infections after bone marrow transplantation: evaluation with radiography and CT. , 1991, Radiology.

[98]  N. Berlinger,et al.  Acute Airway Obstruction Due to Necrotizing Tracheobronchial Aspergillosis in Immunocompromised Patients: A New Clinical Entity , 1989, The Annals of otology, rhinology, and laryngology.

[99]  J. Sidorov.  Aspergillosis in a healthy host. , 1988, Southern medical journal.

[100]  F. Griffin,et al.  Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts. , 1986, Reviews of infectious diseases.

[101]  S. Levitz,et al.  In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. , 1984, The Journal of infectious diseases.

[102]  F. Khan,et al.  Aspergillomas complicating sarcoidosis. A prospective study in 100 patients. , 1984, Chest.

[103]  A. Schaffner,et al.  Killing of Aspergillus spores depends on the anatomical source of the macrophage , 1983, Infection and immunity.

[104]  H. Israel,et al.  Sarcoidosis and aspergilloma. The role of surgery. , 1982, Chest.

[105]  A. Schaffner,et al.  Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. , 1982, The Journal of clinical investigation.

[106]  T. Aldrich,et al.  Invasive aspergillosis of the lung and pericardium in a nonimmunocompromised 33 year old man. , 1981, The American journal of medicine.

[107]  B. Cooper,et al.  Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. , 1977, Annals of internal medicine.

[108]  A. Ostrow,et al.  Sarcoidosis and aspergilloma. , 1969, The American journal of medicine.

[109]  A. Bernard,et al.  Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[110]  F. Martinez,et al.  Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. , 2001, Chest.

[111]  D. Denning.  Chronic forms of pulmonary aspergillosis. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[112]  J. Kemper,et al.  Osteomyelitis of the base of the skull secondary to Aspergillus. , 1997, American journal of otolaryngology.

[113]  T. Walsh,et al.  Granulocyte-macrophage colony-stimulating factor and interferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae. , 1996, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[114]  A. Schaffner.  Macrophage-Aspergillus interactions. , 1994, Immunology series.

[115]  J. Perfect,et al.  Erratum: NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis (American Journal of Medicine (August 1994) 97 (135-144)) , 1994 .

[116]  G. Woods,et al.  Fatal disseminated infection with Aspergillus terreus in immunocompromised hosts. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[117]  J. Latgé,et al.  Virulence of alkaline protease-deficient mutants of Aspergillus fumigatus. , 1993, FEMS microbiology letters.

[118]  P. Greenberger,et al.  The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. , 1991, The Journal of laboratory and clinical medicine.

[119]  O. P. Jaggi,et al.  Allergic bronchopulmonary aspergillosis with coexistent aspergilloma: a long-term followup. , 1989, The Journal of asthma : official journal of the Association for the Care of Asthma.

[120]  F. Meunier.  Empirical antifungal therapy in febrile granulocytopenic patients , 1989 .

[121]  F. Witebsky,et al.  Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. , 1982, The American journal of medicine.